Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAbbott Announces Approval in China for Next-Generation XIENCE V Drug Eluting Stent
Abbott, 09/15/09
Abbott announced that the Chinese State Food and Drug Administration has approved its XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) – the leading cause of death in China. XIENCE V is the only drug eluting stent to have demonstrated superiority over the TAXUS Paclitaxel–Eluting Coronary Stent System in the primary endpoints of two randomized, pivotal clinical trials.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Sanofi Pasteur obtains license from Syntiron to develop & commercialize vaccine to prevent Staphylococcus infections
Sanofi-aventis, 12/17/09
Telmisartan/amlodipine: approved for high blood pressure
Formulary , 12/16/09
Sponsor
Article Search
Sponsor
Sponsor